Your browser doesn't support javascript.
loading
A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
Murtuja, Sheikh; Shilkar, Deepak; Sarkar, Biswatrish; Sinha, Barij Nayan; Jayaprakash, Venkatesan.
Afiliação
  • Murtuja S; Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215 (JH), India.
  • Shilkar D; Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215 (JH), India.
  • Sarkar B; Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215 (JH), India.
  • Sinha BN; Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215 (JH), India.
  • Jayaprakash V; Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215 (JH), India. Electronic address: venkatesanj@bitmesra.ac.in.
Bioorg Med Chem ; 49: 116415, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34601454
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Inibidores de Proteases / Cisteína Endopeptidases / Vírus da Dengue / Proteases 3C de Coronavírus / SARS-CoV-2 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Inibidores de Proteases / Cisteína Endopeptidases / Vírus da Dengue / Proteases 3C de Coronavírus / SARS-CoV-2 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article